Statistics for NeuroPace, (id:6828 NPCE)

Valuation metrics

Market cap

262.19M

Enterprise value

305.60M

Trailing P/E (ttm)

-7.24

Forward P/E

-8.55

PEG ratio

-8.55

Price/Sales (ttm)

3.43

Price/Book (mrq)

27.21

Enterprise Value/Revenue

4.00

Enterprise Value/EBITDA

-13.36

Overview

Shares outstanding

29.20M

Float

11.21M

Shares short

437.93K

% Held by insiders

0.08%

% Held by institutions

0.83%

Average volume (10 days)

132.45K

Average volume (90 days)

Price summary

52-Week low

5.45

52-Week high

18.15

52-Week change

2.18%

Beta

1.80

50-Day moving average

6.89

200-Day moving average

9.63

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-36.74%

Operating margin

-20.15%

Operational effectiveness

Return on assets

-14.74%

Return on equity

-214.55%

Income statement

Revenue (ttm)

2.70

Revenue per share (ttm)

2.70

Quarterly revenue growth (yoy)

Gross profit (ttm)

48.12M

EBITDA

-22,870,000.00

Net income to common (ttm)

-28,091,000.00

Diluted EPS (ttm)

-1.08

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

56.83M

Total cash per share (mrq)

1.90

Total debt (mrq)

73.50M

Total Debt/Equity (mrq)

748.23

Current ratio (mrq)

558.80%

Book value per share (mrq)

0.33

Cash flow

Cash flow statement

-16,493,000.00

Levered free cash flow (LFCF)

-9,622,375.00